Monitoring circulating gammadelta T cells in cancer patients to optimize gammadelta T cell-based immunotherapy

The success of gammadelta (gd) T cell-based immunotherapy, where the cytotoxic activity of circulating gd T lymphocytes is activated by nitrogen-containing bisphosphonates (n-BP), or possibly by bispecific antibodies or the combination of both, requires a profound knowledge of patients´ gd T cells....

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hans-Heinrich eOberg, Christian eKellner, Matthias ePeipp, Susanne eSebens, Sabine eAdam-Klages, Martin eGramatzki, Dieter eKabelitz, Daniela eWesch
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2014-12-01
coleção:	Frontiers in Immunology
Assuntos:	human Monitoring Pancreatic Ductal Adenocarcinoma Gamma Delta T cells Phosphoantigen bispecific antibodies
Acesso em linha:	http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00643/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!